ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE

QR Code

ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE

This review is focused on the main aspects of aspirin therapy in the prevention of various atherothrombosis manifestations and coronary heart disease (CVD). The major mechanism of aspirin action is explained, and additional aspirin benefits, unrelated to its anti-aggregant activity, are described. C...

Full description

Saved in:

Bibliographic Details
Main Author:	M. G. Bubnova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-08-01
Series:	Российский кардиологический журнал
Subjects:	atherothrombosis coronary heart disease aspirin prevention
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1476
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An aspirin a day : what you can do to prevent heart attack, stroke, and cancer /
by: Castleman, Michael
Published: (1993)

MECHANISMS OF CARDIOVASCULAR DISEASES DEVELOPMENT IN OBESITY AND INSULIN RESISTANCE: FOCUS ON ATHEROTHROMBOSIS
by: V. N. Shishkova
Published: (2016-09-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

EVALUATION OF ASPIRIN USAGE SAFETY IN CORONARY BYPASS SURGERY
by: A. M. Chernyavsky, et al.
Published: (2017-10-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

RISK OF RECURRENT THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME AND HIGH PLASMA LEVELS OF D-DIMER
by: A. V. Panina, et al.
Published: (2013-08-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

Hemostasis protein-coding genes, peripheral hemostasis parameters, and atherothrombosis predisposition in patients with cardiovascular disease
by: G. I. Lifshits, et al.
Published: (2011-08-01)

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS
by: E. A. Shelest, et al.
Published: (2015-09-01)

Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01)

Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics?
by: S. G. Kanorskii
Published: (2020-07-01)

Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction
by: R. G. Oganov, et al.
Published: (2005-06-01)

Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease
by: N. V. Lomakin, et al.
Published: (2025-03-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

Aspirin resistance in patients with acute coronary syndrome. Part 2
by: N. S. Frolova, et al.
Published: (2011-04-01)

Aspirin resistance in patients with acute coronary syndrome. Part 1
by: N. S. Frolova, et al.
Published: (2010-12-01)

INHIBITION OF THE FACTOR XA (WITH RIVAROXABAN) SLOW DOWN PROGRESSION, PREVENTS COMPLICATION AND DECREASE MORTALITY IN CORONARY HEART DISEASE
by: V. N. Khirmanov
Published: (2018-04-01)

Aspirin-induced gastrointestinal lesions in patients with chronic coronary artery disease: special aspects and therapeutic options
by: N. Yu. Borovkova, et al.
Published: (2020-04-01)

Prognosis of patients with coronary artery disease and diabetes — what to look for
by: A. A. Nekrasov, et al.
Published: (2024-10-01)

Acute coronary syndrome: how to reduce the residual inflammatory risk?
by: V. I. Shalnev
Published: (2020-03-01)

Prevention of primary stroke in adults and children
by: T. L. Vizilo, et al.
Published: (2021-06-01)

Factors determining homocysteine levels in Russian patients with stable coronary heart disease
by: O. O. Shakhmatova, et al.
Published: (2010-08-01)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015-09-01)

Levels of cytokines and C-reactive protein as treatment effectiveness criteria in patients with coronary heart disease and chronic heart failure
by: E. Yu. Sazhina, et al.
Published: (2008-06-01)

ANTIAGGREGANT THERAPY AND REDUCTION OF HIGH RESIDUAL PLATELET REACTIVITY
by: N. A. Mazur, et al.
Published: (2012-08-01)

ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01)

Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease
by: E. D. Zharkova, et al.
Published: (2023-05-01)

Implementing principles of coronary heart disease secondary prevention into real-world clinical practice
by: D. M. Aronov, et al.
Published: (2007-02-01)

Structural and functional base of coronary heart disease typology
by: A. S. Dimov, et al.
Published: (1970-01-01)

Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01)

CHANGES IN THE MUCOSE OF UPPER GASTROINTESTINAL TRACT IN CORONARY HEART DISEASE
by: B. M. Magomedova, et al.
Published: (2017-12-01)

SIU-ICUD: Prevention of Lethal Prostate Cancer via Modifiable Heart-Healthy Lifestyle Changes, Metrics, and Repurposed Medications
by: Mark A. Moyad, et al.
Published: (2025-06-01)

CORONARY HEART DISEASE IN YOUNG WOMEN: PROBLEMS OF DIAGNOSTICS AND PREVENTION
by: A. Yu. Lebedeva, et al.
Published: (2011-12-01)

MOLECULAR AND GENETIC MARKERS FOR CORONARY HEART DISEASE PROGNOSIS IN ELDERLY PATIENTS
by: N. A. Malygina, et al.
Published: (2009-08-01)

ENDOVASCULAR TREATMENT FOR CHRONIC CORONARY OCCLUSIONS IN PATIENTS WITH CORONARY HEART DISEASE
by: R. O. Shirokov, et al.
Published: (2016-02-01)

Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology
by: M. M. Tanashyan, et al.
Published: (2021-09-01)

Physical activity assessment in coronary heart disease patients: questionnaire ODA-23+
by: V. B. Krasnitskyi, et al.
Published: (1970-01-01)

The role of modern antithrombotic agents in cardiovascular disease prevention
by: O. M. Drapkina, et al.
Published: (1970-01-01)

Modern opportunities of heart rate regulation in coronary heart disease
by: N. Sh. Zagidullin, et al.
Published: (2013-10-01)